Xylem Inc (XYL) Stake Lifted by CENTRAL TRUST Co

CENTRAL TRUST Co grew its position in shares of Xylem Inc (NYSE:XYL) by 60.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,326 shares of the industrial products company’s stock after purchasing an additional 879 shares during the period. CENTRAL TRUST Co’s holdings in Xylem were worth $186,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Flagship Harbor Advisors LLC purchased a new position in shares of Xylem during the 2nd quarter valued at $106,000. Smithfield Trust Co. grew its position in shares of Xylem by 1,690.0% during the 2nd quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock valued at $108,000 after purchasing an additional 1,521 shares in the last quarter. Fort L.P. purchased a new position in shares of Xylem during the 2nd quarter valued at $118,000. Stelac Advisory Services LLC purchased a new position in shares of Xylem during the 2nd quarter valued at $125,000. Finally, Piedmont Investment Advisors LLC bought a new stake in shares of Xylem during the 2nd quarter worth $139,000. Hedge funds and other institutional investors own 85.85% of the company’s stock.

NYSE XYL opened at $79.31 on Monday. Xylem Inc has a 52-week low of $62.24 and a 52-week high of $82.44. The company has a quick ratio of 1.02, a current ratio of 1.43 and a debt-to-equity ratio of 0.86. The firm has a market cap of $14.35 billion, a PE ratio of 33.05, a P/E/G ratio of 1.52 and a beta of 1.22.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.02. The company had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.28 billion. Xylem had a net margin of 7.39% and a return on equity of 19.04%. The firm’s revenue was up 13.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.59 EPS. On average, equities analysts expect that Xylem Inc will post 2.91 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 20th. Shareholders of record on Thursday, August 30th were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 1.06%. The ex-dividend date was Wednesday, August 29th. Xylem’s dividend payout ratio is presently 35.00%.

A number of research firms have recently issued reports on XYL. Berenberg Bank began coverage on shares of Xylem in a report on Wednesday, October 3rd. They set a “sell” rating and a $65.00 price objective for the company. Raymond James began coverage on shares of Xylem in a report on Wednesday, September 5th. They set an “outperform” rating and a $90.00 price objective for the company. Zacks Investment Research raised shares of Xylem from a “sell” rating to a “hold” rating and set a $84.00 price objective for the company in a report on Thursday, August 2nd. Robert W. Baird reaffirmed a “hold” rating and set a $80.00 price objective on shares of Xylem in a report on Wednesday, August 1st. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $78.00 price objective on shares of Xylem in a report on Wednesday, August 1st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and eight have issued a buy rating to the company’s stock. Xylem presently has a consensus rating of “Buy” and a consensus price target of $81.33.

In other Xylem news, insider Paul A. Stellato sold 3,000 shares of the business’s stock in a transaction on Monday, September 10th. The shares were sold at an average price of $78.63, for a total value of $235,890.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Curtis J. Crawford sold 7,500 shares of the business’s stock in a transaction on Tuesday, August 7th. The stock was sold at an average price of $76.26, for a total transaction of $571,950.00. Following the completion of the sale, the director now directly owns 40,421 shares of the company’s stock, valued at $3,082,505.46. The disclosure for this sale can be found here. Insiders sold 49,284 shares of company stock valued at $3,839,982 over the last three months. 0.81% of the stock is currently owned by insiders.

Xylem Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Recommended Story: Short Selling – Explanation For Shorting Stocks

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply